Hong Kong

BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China
  • June 17th, 2013
  • BioLineRx has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharma to commercialize BL-8030 in China.

» Read More...
Featured Research »
Researchers Identify Gene For Aggressive Liver Cancer

Researchers Identify Gene For Aggressive Liver Cancer

Researchers in Singapore have discovered a gene that can be used in the diagnosis and treatment of liver cancer.

Health & Medicine »
Scientists Identify Novel Genetic Markers For Lou Gehrig’s Disease In Han Chinese

Scientists Identify Novel Genetic Markers For Lou Gehrig’s Disease In Han Chinese

Scientists have identified two novel genetic variants associated with amyotrophic lateral sclerosis (ALS), also referred to as Lou Gehrig’s disease, in the Han Chinese population.

Academia »
Times Higher Education Uni Rankings Show Competition Among Asian Tigers

Times Higher Education Uni Rankings Show Competition Among Asian Tigers

Led by Japan in first position, the Asian Tiger economies continue to make progress in the higher education sector.

Tech & Pharma »
BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China

BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China

BioLineRx has signed an out-licensing agreement with Jiangsu Chia-tai Tianqing Pharma to commercialize BL-8030 in China.

Editorials »
Lessons For Asia From The Horse Meat Scandal

Lessons For Asia From The Horse Meat Scandal

What can we in Asia learn from the horsemeat contamination scandal in Europe? David Tan discusses.